WAVE Life Sciences Ltd. WVE

3.78 (0.18) (4.55%) as of 25 Sep
Market cap
$780.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
602.07 302.08 200.35 88.50 150.56 184.50 147.16 174.82 142.50 150.29
Receivables
1.28 1.42 21.09 — — 30.00 20.00 10.00 1.00 —
Other current assets
3.08 7.35 4.02 2.11 5.42 5.11 8.69 10.87 6.99 1.70
Total current assets
614.81 320.39 235.37 98.54 162.56 230.04 185.48 202.27 150.49 151.99
Property, Plant, Equpment (Net)
7.41 10.13 13.08 17.28 22.27 29.20 36.37 39.93 27.33 8.61
Long-term receivables
— — — — — — 30.00 50.00 — —
Long Term Assets (Tax, Deferred)
— — — — — — — — — 0.56
Long-term assets (Other)
3.82 3.82 3.86 3.72 3.80 3.77 14.31 3.74 4.02 3.65
Total non-current assets
23.69 31.81 39.58 47.85 44.44 49.20 98.77 93.67 31.36 12.82
Total Assets
638.50 352.21 274.95 146.39 207.01 279.24 284.25 295.94 181.84 164.81
Accounts Payable
15.70 16.26 12.84 16.92 7.28 13.80 9.07 13.09 7.60 4.94
Accrued Expenses
26.56 21.08 16.83 17.55 14.86 11.97 16.19 14.74 8.90 4.43
Current Part of Capital Lease
— — — — — — — — 0.02 0.06
Current Part of Taxes to Pay
— — — — — — — 0.00 0.00 0.00
Current Revenue (Deferred)
44.44 65.97 150.06 31.56 37.10 91.56 89.65 101.06 1.34 2.71
Other current liabilities
— — — 49.11 51.96 103.53 105.84 1.16 0.34 0.01
Total current liabilities
95.07 110.95 186.44 71.52 64.20 121.04 118.15 130.04 18.19 12.16
Long Term Debt (Total)
— — — 32.12 24.96 25.59 29.30 9.25 3.09 0.02
Non-current Revenue (Deferred)
7.80 6.10 15.60 79.77 77.48 41.48 63.47 73.29 11.46 8.99
Liabilities (Preferred Stock)
7.87 7.87 7.87 7.87 7.87 7.87 7.87 7.87 — —
Non-current Liabilities (Other)
— — — 0.19 — 0.47 1.72 11.39 4.71 0.91
Total non-current liabilities
25.08 31.74 48.88 119.96 110.31 75.42 102.37 92.55 16.17 9.92
Total liabilities
120.14 142.69 235.32 191.48 174.51 196.46 220.52 222.59 34.36 22.07
Additional Paid In Capital
228.37 156.45 129.24 119.44 87.98 71.57 57.28 37.77 22.17 10.03
Preferred Stock (Total)
— — — — — — — 7.87 7.87 7.87
Common Stock (Net)
1,616.48 1,175.18 935.37 802.83 749.85 694.09 539.55 375.15 310.04 215.60
Retained Earnings
(1,326.24) (1,121.86) (1,024.85) (967.34) (805.51) (683.27) (533.36) (339.72) (192.72) (90.48)
Common Equity (Total)
518.36 209.52 39.63 (45.09) 32.50 82.78 63.73 73.35 139.61 134.86
Shareholders Equity (Total)
518.36 209.52 39.63 (45.09) 32.50 82.78 63.73 73.35 147.48 142.74
Shareholders Equity and Liabilities (Total)
638.50 352.21 274.95 146.39 207.01 279.24 284.25 295.94 181.84 164.81
Shares (Common)
187.66 153.04 119.16 86.93 59.84 48.78 34.34 29.47 27.83 23.50
Shares (Preferred)
— — — — — — — 3.90 3.90 3.90
Shareholders Equity (Tangible)
518.36 209.52 39.63 (45.09) 32.50 82.78 63.73 73.35 147.48 142.74
Net Debt
(602.07) (302.08) (200.35) (56.38) (125.61) (158.91) (117.86) (165.57) (139.41) (150.28)
Total Debt
— — — 32.12 24.96 25.59 29.30 9.25 3.09 0.02

Fold the line items

In millions of $ except per-share values · columns are period end dates